Seres Therapeutics, Inc. earnings per share and revenue

MCRB earnings per share for the last quarter are -0.31 USD whereas the estimation was -0.50 USD which accounts for 37.58% surprise. Company revenue for the same period amounts to 65.00 k USD despite the estimated figure of -155.00 k USD. Estimated earnings per share for the next quarter are -0.34 USD, and revenue is expected to reach 250.00 k USD. Also watch annual changes over time to get a bigger picture of MCRB earnings per share and revenue dynamics.